US BANCORP \DE\ - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$1,114
+145.9%
85
+372.2%
0.00%
Q1 2023$453180.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,741,154$24,968,0003.26%
Roubaix Capital, LLC 136,893$1,963,0001.69%
SECTORAL ASSET MANAGEMENT INC 376,678$5,402,0001.09%
EMERALD ADVISERS, LLC 1,068,884$15,328,0000.79%
EMERALD MUTUAL FUND ADVISERS TRUST 929,882$13,335,0000.77%
Perceptive Advisors 941,192$13,497,0000.42%
Novo Holdings A/S 588,308$8,436,0000.42%
ESSEX INVESTMENT MANAGEMENT CO LLC 96,691$1,387,0000.22%
TimesSquare Capital Management, LLC 872,524$12,512,0000.17%
CNA FINANCIAL CORP 30,054$431,0000.15%
View complete list of TREACE MED CONCEPTS INC shareholders